Page last updated: 2024-09-04

levofloxacin and Lymphoma, Large B-Cell, Diffuse

levofloxacin has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chinen, S; Ishizu, M; Mogi, A; Nakashima, Y; Sasaki, H; Takamatsu, Y; Takata, T; Tanaka, T1

Other Studies

1 other study(ies) available for levofloxacin and Lymphoma, Large B-Cell, Diffuse

ArticleYear
Efficacy of oral levofloxacin monotherapy against low-risk FN in patients with malignant lymphoma who received chemotherapy using the CHOP regimen.
    Journal of clinical and experimental hematopathology : JCEH, 2020, Sep-25, Volume: 60, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Fever; Humans; Levofloxacin; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Prednisone; Retrospective Studies; Vincristine; Young Adult

2020